| known also as: |
APC2), Apo-CII, ApoC-II, ID (Apolipoprotein C-II, Anti-APOC2 |
| known also as: |
APC2), Apo-CII, ApoC-II, ID (Apolipoprotein C-II, APOC2 |
| known also as: |
APC2), Apo-CII, ApoC-II, ID (Apolipoprotein C-II, APOC2 |
| known also as: |
APOC2 |
| known also as: |
APC2), Apo-CII, ApoC-II, ID (Apolipoprotein C-II, Anti -APOC2 |
| Other names: |
Apolipoprotein C-II, Apolipoprotein C2, apolipoprotein C-II, apolipoprotein C-II, apolipoprotein C2, apolipoprotein C-II |
| Other gene names: |
APC2, APO-CII, APOC-II, APOC2, MGC75082, APOC2 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Source: Human, Host: Rabbit |
| Species reactivity: |
Human |
| Specificity and cross-reactivity: |
Recognizes human APOC2 |
| Purification method: |
Purified by ammonium sulfate precipitation |
| Form/Appearance: |
0, 09% sodium azide, Supplied as a liquid in PBS |
| Storage and shipping: |
Aliquot to avoid repeated freezing and thawing, Aliquots are stable for at least 12 months, For maximum recovery of product, For optimal long term storage, centrifuge the original vial after thawing and prior to removing the cap, productone should be kept at -20 degrees Celsius, Store at 4 degrees Celsius for short term storage |
| Tested for:: |
Immunohistochemistry (IHC), ELISA (EL/EIA) |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Gene target: |
APC2), Apo-CII, ApoC-II, ID (Apolipoprotein C-II, APOC2 |
| Short name: |
APC2) Antibody, Apo-CII, ApoC-II, ID (Apolipoprotein C-II, APOC2 |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
APC2) (Antibody to), Apo-CII, ApoC-II, ID (Apolipoprotein C-II, apolipoprotein C-II |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
APO-CII and APOC-II, APOC2 and IDBG-306903 and ENSG00000234906 and 344, APOC2 and IDBG-639315 and ENSBTAG00000020558 and 618039, Apoc2 and IDBG-151996 and ENSMUSG00000002992 and 11813, Extracellular, lipoprotein lipase activator activity, this GO :0001523 and retinoid metabolic process and biological process this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005769 and early endosome and cellular component this GO :0006629 and lipid metabolic process and biological process this GO :0006869 and lipid transport and biological process this GO :0007603 and phototransduction, this GO :0008047 : enzyme activator activity, this GO :0008047 : enzyme activator activity and also this GO :0008289 : lipid binding and also this GO :0016004 : phospholipase activator activity and also this GO :0042803 : protein homodimerization activity and also this GO :0043274 : phospholipase binding and also this GO :0055102 : lipase inhibitor activity and also this GO :0060230 : lipoprotein lipase activator activity, this GO :0008289 : lipid binding, this GO :0016004 : phospholipase activator activity, this GO :0042803 : protein homodimerization activity, this GO :0043274 : phospholipase binding, this GO :0055102 : lipase inhibitor activity, this GO :0060230 : lipoprotein lipase activator activity, visible light and biological process this GO :0008047 and enzyme activator activity and molecular function this GO :0008289 and lipid binding and molecular function this GO :0010518 and positive regulation of phospholipase activity and biological process this GO :0010898 and positive regulation of triglyceride catabolic process and biological process this GO :0010902 and positive regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0010916 and negative regulation of very-low-density lipoprotein particle clearance and biological process this GO :0016004 and phospholipase activator activity and molecular function this GO :0016042 and lipid catabolic process and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034362 and low-density lipoprotein particle and cellular component this GO :0034363 and intermediate-density lipoprotein particle and cellular component this GO :0034366 and spherical high-density lipoprotein particle and cellular component this GO :0034370 and triglyceride-rich lipoprotein particle remodeling and biological process this GO :0034371 and chylomicron remodeling and biological process this GO :0034372 and very-low-density lipoprotein particle remodeling and biological process this GO :0034382 and chylomicron remnant clearance and biological process this GO :0034384 and high-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0043086 and negative regulation of catalytic activity and biological process this GO :0043274 and phospholipase binding and molecular function this GO :0043691 and reverse cholesterol transport and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045723 and positive regulation of fatty acid biosynthetic process and biological process this GO :0045833 and negative regulation of lipid metabolic process and biological process this GO :0048261 and negative regulation of receptor-mediated endocytosis and biological process this GO :0051006 and positive regulation of lipoprotein lipase activity and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060230 and lipoprotein lipase activator activity and molecular function this GO :0060697 and positive regulation of phospholipid catabolic process and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070328 and triglyceride homeostasis and biological process, apolipoprotein C-II |
| Identity: |
609 |
| Gene: |
APOC2 |
More about : APOC2 |
| Long gene name: |
apolipoprotein C2 |
| Synonyms gene name: |
apolipoprotein C-II |
| Locus: |
19q13, 32 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
X00568 |
| Entrez gene record: |
344 |
| RefSeq identity: |
NM_000483 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000180847 |